Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -6 of 6
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
5/8/2007
1.
Phase III Randomized Double-Blind Study of Intratumoral CDDP/Epinephrine Injectable Gel for Recurrent or Refractory Squamous Cell Carcinoma of the Head and Neck (Summary Last Modified 04/2000)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
18 and over
Pharmaceutical / Industry
MP-414-94-2
NCI-V95-0676, NCT00002659
Last Modified:
6/1/1998
2.
Phase II Study of Intralesional Cisplatin/Epinephrine Therapeutic Implant for Accessible Solid Tumors (Summary Last Modified 06/98)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
over 18
Pharmaceutical / Industry
MP-403-93-2
NCI-V95-0675
Last Modified:
1/1/2000
3.
Phase II, Open Label, Multicenter Safety and Efficacy Study of Cisplatin-Epinephrine (Intradose MPI-5010) Administered to Patients with Unresectable Intrahepatic Colorectal Metastases (Summary Last Modified 01/2000)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
Pharmaceutical / Industry
MP-405-96-2
NCI-V97-1289
Last Modified:
4/1/2000
4.
Phase II, Open Label, Multicenter Safety and Efficacy Study of Cisplatin-Epinephrine (Intradose MPI-5010) Administered to Patients with Unresectable Primary Hepatocellular Carcinoma (Summary Last Modified 04/2000)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
Pharmaceutical / Industry
MP-417-96-2
NCI-V97-1290, NCT00003044
Last Modified:
2/1/2002
 
First Published:
8/1/2001
5.
Phase II Study of Intratumoral Cisplatin-Epinephrine Injectable Gel and Systemic Paclitaxel and Carboplatin in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck (Summary Last Modified 02/2002)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
Pharmaceutical / Industry
MP-601-00-2
ENH-EH01-102, NCT00022217
Last Modified:
12/13/2007
6.
Phase I Study of Intralesional CDDP/Epinephrine Therapeutic Implant for Primary Liver Cancer or Liver Metastases from GI Primary Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
adult
Pharmaceutical / Industry
MP-43-92-P
NCI-V94-0432
Select All on One Page
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute